Navigation Links
Montana Center for Work Physiology and Exercise Metabolism presents firefighter health study
Date:5/29/2008

MISSOULA

The Montana Center for Work Physiology and Exercise Metabolism (Montana WPEM) will present a human clinical study at the Annual Meeting of the American College of Sports Medicine, showing that wildland firefighters who consumed a yeast based (beta glucan) antioxidant supplement, Wellmune WGP, had far fewer 23 percent upper respiratory tract infections, compared to a similar group of firefighters taking a placebo.

Montana WPEM Director Brent C. Rudy said, Wildland fire suppression crew health is a top concern. We are looking for a way to give the people, who do this demanding, intense work a nutritional edgea way to stay healthy under very difficult, almost combat-like conditions.

The results of the firefighters study show a strong statistical trend that subjects who used Wellmune WGP had better physical health 23 percent fewer upper respiratory tract infections such as, fever, headaches, weakness, coughing, sneezing and stuffy noses, Ruby said The results are consistent with previous clinical research involving marathoners, individuals with high stress lifestyles and the general population.

In a single-blind, random, cross-over design, 54 wildland firefighters from the Bitterroot Hotshots and Great Northern Crews were given Wellmune WGP or placebo for 14 days, followed by a three-day washout (one word: washout) period and another 14-day treatment period. During the course of treatments, subjects kept daily health logs recording cold and flu symptoms and overall feelings of well-being. If subjects recorded any cold symptom (runny or stuffy nose, sore throat, coughing, sneezing, colored discharge) or flu symptom (fever, headache, general aches and pains, fatigue and weakness, chest discomfort, cough) for two consecutive days, they were classified with an upper respiratory tract infection.

There was a strong statistical trend favoring the use of Wellmune WGP for the prevention of upper respiratory tr
'/>"/>

Contact: Dave Walsh
651-256-4606
Strategic Communications
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Montana Center for Work Physiology and Exercise Metabolism Presents Firefighter Health Study
2. Montana Passes Newborn Screening Law for Cystic Fibrosis
3. Actress, Singer, Songwriter Miley Cyrus, Also Known as Hannah Montana, Adds St. Jude Math-A-Thon(R) Video Host to Her Talents
4. Montana State University researchers investigate new suspect in West Nile deaths of pelicans
5. More than 10,000 Medicare Patients in Montana Could Be Hit by Proposed Cuts to Home Oxygen Therapy; Access to Power Wheelchairs Would Also Decrease
6. TriWest and Montana VA Launch PTSD Video Conference to Reach Rural Health Care Providers
7. Montana Health Care Leader Elected Board Chair of National Association
8. Fitworks Fitness Centers Responds to the Growing Adolescent Obesity Rate by Offering Free Summer Memberships to Teens 13-15 Years of Age
9. Deane F. Johnson Center Receives Ronald and Nancy Reagan Award
10. Dartmouth-Hitchcock Medical Center Evaluation Findings Demonstrate Masimo Patient SafetyNet(TM) Delivers Improvements in Clinical Outcomes and Patient Safety on General Care Floors
11. Oregon Cosmetic Vein Center Opens in Portland, Among First on West Coast to Offer Brand New, FDA-Approved Procedures and Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... suicide goes up within a week of getting ... News) -- Emotional stress can put newly diagnosed ... events and suicide, a new study has found. ... diagnosed with prostate cancer between 1961 and 2004. ... cardiovascular event within a year of cancer diagnosis ...
(Date:12/15/2009)... R.I., Dec. 15 Mergers and acquisitions ... expand their reach globally or complete a product ... the integration of safety programs. ,, A new ... Best Practices in a Hearing Conservation Program: US ... Airways and America West led the newly formed ...
(Date:12/15/2009)... by the Technology-based Learning SIG of ASTD,s Atlanta ... eLearning designs. This year nominees, eleven (11) ... The Venza Group entry, a highly engaging modular ... selected as the winner of the "Greater Than ... panel of distinguished judges. While announcing the ...
(Date:12/15/2009)... Inhibiting fatty acid synthesis in brain cancer cells may ... of deadly glioblastomas that are driven by amplified signaling ... a first-of-its-kind study by researchers at UCLA,s Jonsson Comprehensive ... acids for the formation of new membranes. The fatty ... cancer cells, and may be important for regulating cell ...
(Date:12/15/2009)... scientists have found the first potential immunological clue of ... the pandemic H1N1 virus. , The study analyzed ... 15 outpatients and 15 control subjects in 10 Spanish ... August 2009. Researchers from the Hospital Clinico Universitario de ... high levels of a molecule called interleukin 17 in ...
Breaking Medicine News(10 mins):Health News:New White Paper Details Best Practices of an Occupational Hearing Conservation Program: US Airways 2Health News:New White Paper Details Best Practices of an Occupational Hearing Conservation Program: US Airways 3Health News:New White Paper Details Best Practices of an Occupational Hearing Conservation Program: US Airways 4Health News:The Venza Group Received Top Honors at the American Society of Training & Development (ASTD) eLearning Excellence Awards Ceremony Held on December 10, 2009 2Health News:Targeting brain cancer cell metabolism may provide new treatment 2Health News:Targeting brain cancer cell metabolism may provide new treatment 3Health News:First immunological clue to why some H1N1 patients get very ill or die 2
... According to a Norwegian study of 1656 subjects over an ... in the workplace is linked to a significant increase in ... and its surroundings were enrolled in 1985 and asked about ... asthma. ,Then, after 5 years 1656 of the ...
... type 2 diabetes. According to a new survey, they showed ... been selected for a pancreas transplant.// Obesity is a strong ... the immune system destroys the insulin-producing cells of the pancreas. ... insulin, usually in the middle age. ,Pancreas transplantation, ...
... preserve their voice box. Treatment for laryngeal cancer often includes ... to learn to speak through an opening made in the ... that has a drastic impact on the quality of that ... been looking into other treatment approaches for laryngeal cancer. In ...
... is a slow killer that ticks away in one out ... These were among the facts and figures trotted out on ... Day. Gathered in front of the Victoria Statue, Cubbon Park, ... the City Police, and the Bangalore Metropolitan Transport Corporation (BMTC). ...
... Stress on human life has been increasing day by day.It ... a more healthy and peaceful life style.//This article is ... get angry for trivial things which does not concern us.But ... life threatning cardiac arrest in patients with heart disease by ...
... there's a firm connection between viral infection and pre-cancerous lesions ... human papillomavirus (HPV)// may increase the risk of cervical cancer. ... history of abnormal cervical cell growth were followed for ten ... another two years later. Those who were free of HPV ...
Other Medicine News:
(Date:12/15/2009)... YORK, Dec. 15 Reportlinker.com announces ... available in its catalogue: ,, Boehringer ... http://www.reportlinker.com/p0168539/Boehringer-Ingelheim-GmbH-PharmaVitae-Profile.html ,, Introduction ,, ... performance for Boehringer Ingelheim in the Rx ... portfolio and pipeline analysis and assessment of ...
(Date:12/15/2009)... -- Reportlinker.com announces that a new ... its catalogue: ,, The Future ... to 2015, Competitive Benchmarking, Product Pipeline ... http://www.reportlinker.com/p0168102/The-Future-of-HIV-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ,, Summary ... latest research "The Future of HIV ...
(Date:12/15/2009)... Belgium, Dec. 15 Ghent University Hospital ... world to pioneer radiotherapy treatments using arc therapy, ... and efficient RapidArc radiotherapy technology from Varian Medical ... patient was treated in just 75 seconds, over ... treatments. ,, "This treatment would have taken more ...
Breaking Medicine Technology:Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 2Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 3Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 4Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 5Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 6Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 7Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12European Radiotherapy Pioneers Deliver First Varian RapidArc(TM) Treatment for Rectal Carcinoma Patient 2European Radiotherapy Pioneers Deliver First Varian RapidArc(TM) Treatment for Rectal Carcinoma Patient 3New Research Shows Over use of Asthma Rescue Inhalers Substantially Reduced Through Pharmacist initiated Physician Intervention 6226 1New Research Shows Over use of Asthma Rescue Inhalers Substantially Reduced Through Pharmacist initiated Physician Intervention 6226 2New Research Shows Over use of Asthma Rescue Inhalers Substantially Reduced Through Pharmacist initiated Physician Intervention 6226 3Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of Hematology 6223 1Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of Hematology 6223 2Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of Hematology 6223 3Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of Hematology 6223 4Lexicon Announces Positive Phase 2 Results of LX1031 in Non Constipating Irritable Bowel Syndrome 6220 1Lexicon Announces Positive Phase 2 Results of LX1031 in Non Constipating Irritable Bowel Syndrome 6220 2Lexicon Announces Positive Phase 2 Results of LX1031 in Non Constipating Irritable Bowel Syndrome 6220 3Lexicon Announces Positive Phase 2 Results of LX1031 in Non Constipating Irritable Bowel Syndrome 6220 4Lexicon Announces Positive Phase 2 Results of LX1031 in Non Constipating Irritable Bowel Syndrome 6220 5
... Nov. 24 A new cancer treatment is,realizing ... treatment, a patient,s large, stage 4 tumor was ... of treatment, it no longer could be definitely,identified ... to nine months,after diagnosis. NeoPlas Innovation,s combination of ...
... moderate to severe acute pain and their health-care providers will ... Johnson Pharmaceutical Research & Development, L.L.C., (J&JPRD), announced that the ... for the relief of moderate to severe acute pain in ... , Tapentadol is a new centrally acting ...
Other Medicine Technology:New Cancer Treatment Shrinks Pancreatic Tumor 2FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain 2FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain 3FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain 4FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain 5FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain 6
The Escape Basket offers a side-by-side approach, unique to the market, for using a nitinol basket and holmium laser fiber together-providing physician control and independent manipulation of both th...
Simple, Effective Laparoscopic Irrigation Pumps from the Market Leader...
The Surgiflex WAVE XP couples the state-of-the-art Surgiflex WAVE Probe with the convenience of a truly portable battery-powered pump....
... is a minimally invasive, highly effective surgical ... incontinence. GYNECARE TVT is positioned close to ... and when needed, TVT provides tension-free support ... The procedure takes approximately 20 to 30 ...
Medicine Products: